摘要
因冠状动脉狭窄而致的缺血性心脏病是世界范围内致死的首要原因。基于大量动物试验的成功,治疗性血管再生已经步入了临床阶段。现对这方面的一些临床研究进行了总结,虽然临床上对血管再生的安全性有较多的肯定,但是临床上血管再生的结果却远不如动物实验理想。为进一步阐明冠心病时血管再生的治疗方法,还需要有大规模的随机、双盲、安慰剂对照试验。
Ischemic heart disease was the first causes of death in the world. The therapeutic angiogenesis has been step into the clinical stage because of the success in animal studies. The results of angiogenesis in clinic were not as good as it in animal study,though its safety has been confirmed. More large scale,double blinded,controlled trials were necessary in order to find a better therapeutic angiogenesis method in clinic.
出处
《心血管病学进展》
CAS
2005年第B08期46-48,共3页
Advances in Cardiovascular Diseases
关键词
血管再生
冠心病
生长因子
Angiogenesis
Coronary heart disease
Growth factor
